ZNF642 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.429400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.952300E-02
Normal-vs-Stage2
2.497800E-01
Normal-vs-Stage3
8.427800E-02
Normal-vs-Stage4
2.391600E-01
Stage1-vs-Stage2
9.872200E-01
Stage1-vs-Stage3
3.305400E-01
Stage1-vs-Stage4
6.733000E-01
Stage2-vs-Stage3
2.333800E-01
Stage2-vs-Stage4
5.825200E-01
Stage3-vs-Stage4
2.991400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.427000E-01
Normal-vs-AfricanAmerican
7.960000E-02
Normal-vs-Asian
1.408000E-02
Caucasian-vs-AfricanAmerican
7.970800E-01
Caucasian-vs-Asian
3.912000E-01
AfricanAmerican-vs-Asian
3.924800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.084300E-03
Normal-vs-Female
2.531800E-01
Male-vs-Female
4.810000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.822030E-01
Normal-vs-Age(41-60Yrs)
2.842600E-01
Normal-vs-Age(61-80Yrs)
2.599500E-03
Normal-vs-Age(81-100Yrs)
2.244800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.991200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.381800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.957600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.908500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.952000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.721800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.016800E-01
Normal-vs-Daily Drinker
1.939220E-01
Normal-vs-Weekly Drinker
2.623200E-01
Normal-vs-Occasional Drinker
2.839600E-01
Normal-vs-Social Drinker
2.780100E-02
Non Drinker-vs-Daily Drinker
7.867200E-01
Non Drinker-vs-Weekly Drinker
2.014000E-01
Non Drinker-vs-Occasional Drinker
4.379600E-02
Non Drinker-vs-Social Drinker
1.080420E-01
Daily Drinker-vs-Weekly Drinker
1.459010E-01
Daily Drinker-vs-Occasional Drinker
2.650100E-02
Daily Drinker-vs-Social Drinker
7.937800E-02
Weekly Drinker-vs-Occasional Drinker
6.418800E-01
Weekly Drinker-vs-Social Drinker
7.772000E-01
Occasional Drinker-vs-Social Drinker
9.079000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.658200E-01
Normal-vs-Grade 2
7.354400E-01
Normal-vs-Grade 3
7.894400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.732100E-02
Grade 1-vs-Grade 3
2.462400E-01
Grade 1-vs-Grade 4
7.658200E-01
Grade 2-vs-Grade 3
3.137000E-01
Grade 2-vs-Grade 4
7.354400E-01
Grade 3-vs-Grade 4
7.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.212600E-01
Normal-vs-NonDiabetic
2.398700E-03
Diabetic-vs-NonDiabetic
5.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.654300E-02
Normal-vs-NoPancreatitis
2.342200E-01
Pancreatitis-vs-NoPancreatitis
8.454000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.295000E-01
Normal-vs-N1
2.524200E-01
N0-vs-N1
3.981200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.134600E-01
Normal-vs-TP53-NonMutant
9.440500E-03
TP53-Mutant-vs-TP53-NonMutant
9.695600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
